JPH203, a LAT1 inhibitor, alleviates steroid-resistant murine airway inflammation mediated by Th17 cells

Affiliations

• ¹ Department of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Shimotsuga, Japan.
• ² Cancer Immunology Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
• ³ Department of Disease Model, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
• ⁴ Laboratory of Immunopharmacology, Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan.
• ⁵ Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, Shimotsuga, Japan.
• ⁶ J-Pharma Co., Ltd., Yokohama, Japan.